Etiology‐dependent molecular mechanisms in human hepatocarcinogenesis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Hepatology

• Publication date

  2007-12-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.22033PMID 18161050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models

  2008cited by this paper
• Mouse translation elongation factor eEF1A‐2 interacts with Prdx‐I to protect cells against apoptotic death induced by oxidative stress

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.

  2007cited by this paper
• Binding of Elongation Factor eEF1A2 to Phosphatidylinositol 4-Kinase β Stimulates Lipid Kinase Activity and Phosphatidylinositol 4-Phosphate Generation*

  2007cited by this paper
• eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration

  2007cited by this paper
• Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

  2007cited by this paper
• Fibroblast growth factor signaling in embryonic and cancer stem cells

  2006cited by this paper
• A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.

  2006cited by this paper
• Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach

  2006cited by this paper
• Hepatocellular carcinoma pathogenesis: from genes to environment

  2006cited by this paper
• Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

  2006cited by this paper
• Involvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus

  2006cited by this paper
• Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

  2006cited by this paper
• Detection of chromosomal imbalances in retinoblastoma by matrix‐based comparative genomic hybridization

  2005cited by this paper
• Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours

  2005cited by this paper
• Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade – results of an explorative CGH meta-analysis

  2005cited by this paper
• Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.

  2005cited by this paper
• Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis

  2004cited by this paper
• Analysis of array CGH data: from signal ratio to gain and loss of DNA regions

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Factors of transforming growth factor β signalling are co-regulated in human hepatocellular carcinoma

  2004cited by this paper
• Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

  2003cited by this paper
• Statistical issues in cDNA microarray data analysis.

  2003cited by this paper
• PTK2 and EIF3S3 genes may be amplification targets at 8q23‐q24 and are associated with large hepatocellular carcinomas

  2003cited by this paper
• Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target

  2003cited by this paper
• A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice.

  2002cited by this paper
• Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity.

  2002cited by this paper
• Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer

  2002cited by this paper
• MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo.

  2002cited by this paper
• Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

  2002cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Hepatocellular carcinoma

  2000cited by this paper
• Epidemiology of Primary Liver Cancer

  1999cited by this paper
• Detection of hepatitis C virus in paraffin‐embedded liver biopsies of patients negative for viral RNA in serum

  1999cited by this paper
• Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances

  1997cited by this paper
• Genetic analysis of benign, low-grade, and high-grade ovarian tumors.

  1995cited by this paper
• Molecular cytogenetics of human breast cancer.

  1994cited by this paper
• A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.

  1991cited by this paper
• [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

  1987cited by this paper
• Hepatocellular carcinoma.

  1986cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Kinase suppressor of Ras 1 (KSR1) promotes liver carcinogenesis via activation of the RAS/RAF/MEK/ERK signaling pathway

  2025cites this paper
• Knockdown of the EEF1A2 gene reduces lung cancer brain metastasis by downregulating the BCL10/NFκB pathway

  2025cites this paper
• Multidimensional Regulatory Mechanisms and Targeting Strategies of the eEF1 Family in RNA Virus Infection

  2025cites this paper
• New insights into biomarkers and risk stratification to predict hepatocellular cancer

  2025influential citation
• FXR splicing by SF3B3 promotes MYC-driven hepatocarcinogenesis.

  2025cites this paper
• Chromosome 8q24 amplification associated with human hepatocellular carcinoma predicts MYC/ZEB1/MIZ1 transcriptional regulation

  2024influential citation
• The Combination of Sorafenib and PGV-1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c-Myc Suppression in an Additive Manner: In Vitro Studies

  2024cites this paper
• A novel MYC-ZNF706-SLC7A11 regulatory circuit contributes to cancer progression and redox balance in human hepatocellular carcinoma

  2024cites this paper
• MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges

  2024cites this paper
• The eEF1A Protein in Cancer: Clinical Significance, Oncogenic Mechanisms, and Targeted Therapeutic Strategies.

  2024cites this paper
• Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges

  2024cites this paper
• Regulation of KIF23 by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma.

  2024cites this paper
• Oncogenic activation of EEF1A2 expression: a journey from a putative to an established oncogene

  2024influential citation
• A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma

  2024cites this paper
• Comparative Clinicopathological and Genomic Analysis of Hepatocellular Neoplasm, NOS and Hepatoblastoma.

  2023cites this paper
• Characterization of cancer subtypes associated with clinical outcomes by multi-omics integrative clustering

  2023cites this paper
• Genomic Analysis in the Categorization of Poorly Differentiated Primary Liver Carcinomas

  2023cites this paper
• MYC in liver cancer: mechanisms and targeted therapy opportunities

  2023cites this paper
• Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer

  2023cites this paper
• KIF23 regulation by miR-107 controls replicative tumor cell fitness in mouse and human hepatocellular carcinoma

  2023cites this paper
• Cabozantinib inhibits HBV-RNA transcription by decreasing STAT3 binding to the enhancer region of cccDNA

  2023cites this paper
• A Novel Transgenic Mouse Model Implicates Sirt2 as a Promoter of Hepatocellular Carcinoma

  2023cites this paper
• Converged DNA Damage Response Renders Human Hepatocellular Carcinoma Sensitive to CDK7 Inhibition

  2022cites this paper
• Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?

  2022cites this paper
• Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors

  2022cites this paper
• [Pathology of hepatocellular carcinoma].

  2022cites this paper
• MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities

  2022cites this paper
• Serum Response Factor (SRF) Drives the Transcriptional Upregulation of the MDM4 Oncogene in HCC

  2021cites this paper
• The Expression and Function of Circadian Rhythm Genes in Hepatocellular Carcinoma

  2021cites this paper
• EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling

  2021cites this paper
• Increased Expression of eEF1A2 and PI3K-Akt Signaling Pathway Genes Promotes The Progression of Cervical Cancer

  2021cites this paper
• Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription

  2021cites this paper
• Isotretinoin and Thalidomide Down-Regulate c-MYC Gene Expression and Modify Proteins Associated with Cancer in Hepatic Cells

  2021cites this paper
• Development and validation of prognostic markers in sarcomas base on a multi-omics analysis

  2021cites this paper
• Sodium Pump Na + /K + ATPase Subunit α1-Targeted Positron Emission Tomography Imaging of Hepatocellular Carcinoma in Mouse Models

  2021cites this paper
• [EEFSEC knockdown inhibits proliferation, migration and invasion of prostate cancer cells in vitro].

  2021cites this paper
• Correlating genomic copy number alterations with clinicopathologic findings in 75 cases of hepatocellular carcinoma

  2021influential citation
• MicroRNA‐206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c‐Myc mice

  2021cites this paper
• A Review of the Integrative Treatment Approach Using the Intravenous Alpha-Lipoic Acid/Low Dose Naltrexone (ALA/N) Protocol for Cancer and a Description of the Long-Term Survival of a Woman with Hepatocellular Carcinoma

  2021cites this paper
• Correlating genomic copy number alterations with clinicopathologic findings in a case series of hepatocellular carcinoma

  2020influential citation
• Targeted delivery of siRNAs against hepatocellular carcinoma-related genes by a galactosylated polyaspartamide copolymer.

  2020cites this paper
• Genomic Landscape of HCC

  2020cites this paper
• MAL2-Induced Actin-Based Protrusion Formation is Anti-Oncogenic in Hepatocellular Carcinoma

  2020cites this paper
• LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma

  2020cites this paper
• A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma

  2020cites this paper
• Hepatic oxidative stress, up-regulation of pro-inflammatory cytokines, apoptotic and oncogenic markers following 2-methoxyethanol administrations in rats

  2020cites this paper
• MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?

  2020cites this paper
• Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer

  2020cites this paper
• A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma

  2020cites this paper
• Predictive value of hypoxia, metabolism and immune factors for prognosis in hepatocellular carcinoma: a retrospective analysis and multicenter validation study

  2020cites this paper
• Oncogenic driver genes and tumor microenvironment determine the type of liver cancer

  2020cites this paper
• Hepatitis B Virus DNA Polymerase Displays an Anti-Apoptotic Effect by Interacting with Elongation Factor-1 Alpha-2 in Hepatoma Cells

  2020cites this paper
• Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma

  2019cites this paper
• High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

  2019cites this paper
• Hepatocellular Carcinoma: Translational Precision Medicine Approaches

  2019cites this paper
• Translation control of the immune checkpoint in cancer and its therapeutic targeting

  2019cites this paper
• Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma

  2019cites this paper
• Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression

  2019cites this paper
• PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy.

  2019cites this paper
• Hepatic stellate cells transmigration and remodeling are related to CCN3 in oxaliplatin-resistant hepatocellular carcinoma

  2018cites this paper
• Cytoplasmic localization of the cell polarity factor scribble supports liver tumor formation and tumor cell invasiveness

  2018cites this paper
• MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?

  2018cites this paper
• Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness

  2018cites this paper
• The master regulator FUBP1: its emerging role in normal cell function and malignant development

  2018cites this paper
• MDM 2p 53 Interactions in Human Hepatocellular Carcinoma : What Is the Role of Nutlins and New Therapeutic Options ?

  2018cites this paper
• Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines

  2018cites this paper
• Behavioural testing and general phenotyping of mice with mutations in Eef1a2 to investigate autism, intellectual disability and epilepsy

  2018cites this paper
• Identification of a Specific Translational Machinery via TCTP–EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA)*

  2018cites this paper
• The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4.

  2017cites this paper
• Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs.

  2017cites this paper
• c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease

  2017cites this paper
• Characterization of FoxO 3 in ROS and DNA damage-induced hepatocellular carcinoma

  2017cites this paper
• MYC‐driven inhibition of the glutamate‐cysteine ligase promotes glutathione depletion in liver cancer

  2017cites this paper
• MYC Deregulation in Primary Human Cancers

  2017cites this paper
• Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients

  2017cites this paper
• Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma

  2017cites this paper
• Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma

  2017cites this paper
• Silencing IGF‐II impairs C‐myc and N‐ras expressions of SMMC‐7721 cells via suppressing FAK/PI3K/Akt signaling pathway

  2017cites this paper
• N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.

  2016cites this paper
• Enhanced angiogenesis, hypoxia and neutrophil recruitment during Myc-induced liver tumorigenesis in zebrafish

  2016cites this paper
• Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections

  2016influential citation
• Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives

  2016cites this paper
• A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma

  2016cites this paper
• Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background

  2016cites this paper
• Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects.

  2016influential citation
• Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti‐cancer therapy

  2016cites this paper
• Heterogeneity of Hepatocellular Carcinoma

  2016cites this paper
• Angiotensin II Enhances Proliferation and Inflammation through AT1/PKC/NF-κB Signaling Pathway in Hepatocellular Carcinoma Cells

  2016cites this paper
• Long noncoding RNA HULC modulates the phosphorylation of YB‐1 through serving as a scaffold of extracellular signal–regulated kinase and YB‐1 to enhance hepatocarcinogenesis

  2016cites this paper
• Monocytes promote liver carcinogenesis in an oncogene-specific manner.

  2016influential citation
• FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.

  2016cites this paper
• Molecular Profiling of Human Hepatocellular Carcinoma

  2016cites this paper
• Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.

  2016cites this paper
• Application of Clinical Bioinformatics

  2016cites this paper
• The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections

  2015influential citation
• Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment.

  2015cites this paper
• Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease.

  2015cites this paper
• Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression

  2015cites this paper
• A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.

  2015cites this paper
• CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression

  2015cites this paper